Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,824 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Author Correction: Toll-like receptor 9 protects non-immune cells from stress by modulating mitochondrial ATP synthesis through the inhibition of SERCA2.
Shintani Y, Drexler HC, Kioka H, Terracciano CM, Coppen SR, Imamura H, Akao M, Nakai J, Wheeler AP, Higo S, Nakayama H, Takashima S, Yashiro K, Suzuki K. Shintani Y, et al. Among authors: takashima s. EMBO Rep. 2024 Apr;25(4):2145. doi: 10.1038/s44319-024-00100-1. EMBO Rep. 2024. PMID: 38429580 Free PMC article.
Alternative mRNA splicing events and regulators in epidermal differentiation.
Takashima S, Sun W, Otten ABC, Cai P, Peng SI, Tong E, Bui J, Mai M, Amarbayar O, Cheng B, Odango RJ, Li Z, Qu K, Sun BK. Takashima S, et al. Cell Rep. 2024 Mar 26;43(3):113814. doi: 10.1016/j.celrep.2024.113814. Epub 2024 Feb 23. Cell Rep. 2024. PMID: 38402585 Free article.
Corticosteroids impair epithelial regeneration in immune-mediated intestinal damage.
Arnhold V, Chang WY, Jansen SA, Thangavelu G, Calafiore M, Vinci P, Fu YY, Ito T, Takashima S, Egorova A, Kuttiyara J, Perlstein A, van Hoesel M, Liu C, Blazar BR, Lindemans CA, Hanash AM. Arnhold V, et al. Among authors: takashima s. J Clin Invest. 2024 Feb 13;134(7):e155880. doi: 10.1172/JCI155880. J Clin Invest. 2024. PMID: 38349762 Free PMC article.
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Gastric Cancer Cohort.
Kawazoe A, Yamamoto N, Sugimoto N, Kawakami H, Oshima T, Yamaguchi K, Hino K, Hirao M, Kurokawa Y, Kawakami T, Tsuda M, Hara H, Kaname S, Matsuoka D, Otake Y, Yasuda K, Takase T, Takashima S, Semba T, Muro K. Kawazoe A, et al. Among authors: takashima s. Clin Cancer Res. 2024 Apr 1;30(7):1264-1272. doi: 10.1158/1078-0432.CCR-23-1768. Clin Cancer Res. 2024. PMID: 38295160 Free PMC article. Clinical Trial.
1,824 results